For this to be the case, given our findings, we would expect that lactoferrin would be more costly to produce, or have more costly consequences associated with elevation, than does sIgA, and would therefore only be elevated when an infant experienced an illness and required additional lactoferrin to help fight the infection. This evidence concerns the gene LTF and infection.